plerixafor has been researched along with Injuries, Multiple in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beattie, LA; Ducey, EJ; Fatanmi, OO; Seed, TM; Singh, VK; Wise, SY | 1 |
Bach, HH; Gamelli, RL; LaPorte, HM; Majetschak, M; Wong, YM | 1 |
2 other study(ies) available for plerixafor and Injuries, Multiple
Article | Year |
---|---|
Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation combined injury in mice.
Topics: alpha-Tocopherol; Animals; Benzylamines; Combined Modality Therapy; Cyclams; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Male; Mice; Multiple Trauma; Peripheral Blood Stem Cell Transplantation; Radiation Dosage; Radiation Injuries; Radiation-Protective Agents; Survival Rate; Treatment Outcome; Wounds, Penetrating | 2014 |
Pharmacological targeting of chemokine (C-X-C motif) receptor 4 in porcine polytrauma and hemorrhage models.
Topics: Animals; Benzylamines; Cyclams; Fluid Therapy; Hemorrhage; Heterocyclic Compounds; Multiple Trauma; Receptors, CXCR4; Survival Rate; Swine; Ubiquitin | 2016 |